Sort
82,697 grants matching “vaccine development”
Preclinical Evaluation of Novel Ad/MVA and Ad/Protein HIV-1 Vaccines
$1,034,318Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2012 · AI
Development Of Flow Cytometric Technologies For Immune Assays
$1,034,161Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2014 · AI
Development Of Flow Cytometric Technologies For Immune Assays
$1,034,161Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Advanced Development of Vaccines for Filoviruses
$1,033,940John Eldridge · Auro Vaccines Llc · N01 · FY2024 · AI
Pediatric AIDS Clinical Trials Group
$1,033,769St. Jude Children'S Research Hospital · U01 · FY2004 · AI
Engineering Novel Enteroid Models for Understanding Human Enteric Disease
$1,033,746Mary Kolb Estes · Baylor College Of Medicine · U19 · FY2018 · AI
Engineering Novel Enteroid Models for Understanding Human Enteric Disease
$1,033,746Mary Kolb Estes · Baylor College Of Medicine · U19 · FY2017 · AI
Engineering Novel Enteroid Models for Understanding Human Enteric Disease
$1,033,745Mary Kolb Estes · Baylor College Of Medicine · U19 · FY2019 · AI
Administration
$1,033,701John R. Murphy · Boston University Medical Campus · UC7 · FY2014 · AI
Developmental Core
$1,033,694Elizabeth A Klonoff · San Diego State University · U54 · FY2010 · CA
Multivalent display of anthrax toxin inhibitors
$1,033,563Scripps Research Institute · P01 · FY2003 · AI
Global Cancer Health
$1,033,509Philip Castle · Division Of Cancer Epidemiology And Genetics · ZIA · FY2022 · CA
Engineering Novel Enteroid Models for Understanding Human Enteric Disease
$1,033,439Mary Kolb Estes · Baylor College Of Medicine · U19 · FY2016 · AI
Regulatory Compliance
$1,033,298David Beasley · University Of Texas Med Br Galveston · UC7 · FY2011 · AI
Malaria Parasite Ligands And Host Cell Receptors
$1,033,057Louis Miller · National Institute Of Allergy And Infectious Diseases · ZIA · FY2015 · AI
Supporting RADx Technology Development: Leveraging International Networks and Clinical Context
$1,032,628Yukari C Manabe · Johns Hopkins University · U54 · FY2022 · EB
The mucosal immune system: effects of aging and chronic antigenic stimulation
$1,032,611Rita Brickman Effros · University Of California Los Angeles · R01 · FY2010 · AG
PROTOZOAN PURINE PHOSPHORIBOSYLTRANSFERASES AS TARGETS TO TREAT MALARIA, AFRICAN TRYPANOSOMIASIS AND CHAGAS'S DISEASE
$1,032,586Thomas Meek · Texas A&M Agrilife Research · R01 · FY2018 · AI
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
$1,032,433William Douglas Figg · Division Of Clinical Sciences - Nci · ZIC · FY2018 · CA
Immunity to Pneumonic Tularemia
$1,032,095Catharine Bosio · National Institute Of Allergy And Infectious Diseases · ZIA · FY2009 · AI
Supported employment to create a community culture of SARS-CoV-2 rapid testing among people who inject drugs: PeerConnect2Test
$1,032,060Camille C Cioffi · University Of Oregon · U01 · FY2023 · DA
Engineering Novel Enteroid Models for Understanding Human Enteric Disease
$1,032,025Mary Kolb Estes · Baylor College Of Medicine · U19 · FY2015 · AI
Project 4: PK-PD of a Combination Antiretroviral Intravaginal Ring in Women
$1,031,835Kathleen Listiak Vincent · Oak Crest Institute Of Science · U19 · FY2017 · AI
The Charge Study: Childhood Autism Risks from Genetics and the Environment
$1,031,807Irva Hertz-Picciotto · University Of California At Davis · R01 · FY2007 · ES
Monitoring SIV reservoirs with whole body immunoPET
$1,031,739Francois J Villinger · Emory University · R01 · FY2014 · AI